PLAINSBORO, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a leading global medical technology company, today announced positive findings from its Cadence® Total Ankle System  retrospective study. Tim Daniels, MD, FRCSC, Professor, University of

Acquisition Adds New, Minimally Invasive Platform for Neurosurgery PLAINSBORO, N.J., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it has acquired Rebound Therapeutics, developers of

PLAINSBORO, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 5, 2019 at 1:55 p.m.

Adds Unique Solution to Integra’s Neurocritical Care Offering PLAINSBORO, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that it has acquired Arkis Biosciences Inc.

Reported revenues increased 4.8% to $383.6 million; organic revenues increased 6.6%  GAAP and adjusted earnings per diluted share were $0.34 and $0.73, respectively The Company reaffirms revenue guidance and updates EPS guidance PLAINSBORO, N.J., July 24, 2019 (GLOBE NEWSWIRE) -- Integra

PLAINSBORO, N.J., July 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2019 financial results on Wednesday, July 24, 2019, prior to market open.

PLAINSBORO, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly-created role of chief operating officer (COO) and appointed Carrie Anderson as chief

PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On Wednesday, June 5, 2019 at 4:30 p.m.

PLAINSBORO, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May: On Tuesday, May 14, 2019 at 4:20 p.m.

Reported revenues amounted to $359.7 million; organic revenues increased 3.1%  GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance for the full-year 2019 PLAINSBORO, N.J., April 24, 2019 (GLOBE NEWSWIRE) --